UBS AM’s Kestra Medical Technologies KMTS Stock Holding History

UBS AM’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.84K	Hold	151	–	–	﹤0.01%	3443
2026 Q1	$3.01K	Buy	151 +121	+403%	+$2.85K	﹤0.01%	3533
2025 Q4	$796	Buy	+30	New	+$773	﹤0.01%	3207

Other funds holding KMTS

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Andera Partners Paris $206M AUM

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM's KMTS Position: Q2 2026 in Review

UBS AM held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 151 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

UBS AM first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

UBS AM held 151 shares of Kestra Medical Technologies worth $3.84K as of Q2 2026.
UBS AM left its Kestra Medical Technologies share count unchanged in Q2 2026.
Kestra Medical Technologies made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3443 holding.
UBS AM first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.